Immunome (NASDAQ:IMNM) Earns Outperform Rating from Wedbush
Wedbush reissued their outperform rating on shares of Immunome (NASDAQ:IMNM – Free Report) in a report issued on Monday, RTT News reports. They currently have a $12.00 price objective on the stock. Immunome Stock Down 0.4 % Shares of Immunome stock opened at $11.95 on Monday. The stock has a market capitalization of $510.62 million, […]
More Stories
Bridgemarq Real Estate Services Inc. (TSE:BRE) Increases Dividend to $0.11 Per Share
Bridgemarq Real Estate Services Inc. (TSE:BRE – Get Free Report) declared a monthly dividend on Friday, October 18th, TickerTech reports....
Whitecap Resources Inc. Plans Dividend of $0.04 (OTCMKTS:SPGYF)
Whitecap Resources Inc. (OTCMKTS:SPGYF – Get Free Report) declared a dividend on Saturday, October 19th, investing.com reports. Shareholders of record...
Origin Agritech (NASDAQ:SEED) Receives New Coverage from Analysts at StockNews.com
StockNews.com started coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a research report report published on Friday....
Texas Capital Bancshares (NASDAQ:TCBI) Price Target Increased to $79.00 by Analysts at Hovde Group
Texas Capital Bancshares (NASDAQ:TCBI – Free Report) had its price target upped by Hovde Group from $73.00 to $79.00 in...
Bitcoiva Hits 1-Day Volume of $265,227.57 (BCA)
Bitcoiva (BCA) traded up 1.9% against the U.S. dollar during the 24-hour period ending at 7:00 AM ET on October...
Dent (DENT) Hits Market Cap of $89.23 Million
Dent (DENT) traded 1.4% higher against the dollar during the 1-day period ending at 7:00 AM E.T. on October 19th....